Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

February 2011 - FRMC

Department

News Connection
02/15/2011

Tori Socha

Tori Socha
Herpes zoster (also known as shingles) is a vesicular rash caused by reactivation of varicella zoster virus.
Herpes zoster (also known as shingles) is a vesicular rash caused by reactivation of varicella zoster virus.
Herpes zoster (also known as...
02/15/2011
First Report Managed Care
News Connection
02/15/2011

Kerri Fitzgerald

Kerri Fitzgerald
Although the use of combination vaccines is increasing in pediatrics, physicians may face financial trouble when incorporating these vaccines into practice.
Although the use of combination vaccines is increasing in pediatrics, physicians may face financial trouble when incorporating these vaccines into practice.
Although the use of combination...
02/15/2011
First Report Managed Care
Conference Insider
02/15/2011

Tim Casey

Tim Casey
A pooled analysis of a phase 3, multicenter, randomized, placebo-controlled study found that patients taking low- and high-dose colchicine were not significantly more likely to have adverse events (AEs) compared with a placebo group. 
A pooled analysis of a phase 3, multicenter, randomized, placebo-controlled study found that patients taking low- and high-dose colchicine were not significantly more likely to have adverse events (AEs) compared with a placebo group. 
A pooled analysis of a phase 3,...
02/15/2011
First Report Managed Care
Conference Insider
02/15/2011

Alice Goodman

Alice Goodman
Many patients with rheumatoid arthritis (RA) are not being treated appropriately, according to 2 studies presented at the ACR meeting. 
Many patients with rheumatoid arthritis (RA) are not being treated appropriately, according to 2 studies presented at the ACR meeting. 
Many patients with rheumatoid...
02/15/2011
First Report Managed Care
Department
02/15/2011

Alice Goodman

Alice Goodman
A combination tablet dubbed HZT-501 reduces gastrointestinal ulcers overall in chronic nonsteroidal antiinflammatory drug users.
A combination tablet dubbed HZT-501 reduces gastrointestinal ulcers overall in chronic nonsteroidal antiinflammatory drug users.
A combination tablet dubbed...
02/15/2011
First Report Managed Care
Department
02/15/2011

Alice Goodman

Alice Goodman
Atlanta—Uveitis (eye inflammation) poses a substantial economic burden, and associated costs increase with the number of uveitis-related medical visits. In patients who develop uveitis-related blindness, direct and indirect costs are...
Atlanta—Uveitis (eye inflammation) poses a substantial economic burden, and associated costs increase with the number of uveitis-related medical visits. In patients who develop uveitis-related blindness, direct and indirect costs are...
Atlanta—Uveitis (eye...
02/15/2011
First Report Managed Care
Department
02/15/2011

Alice Goodman

Alice Goodman
Ongoing treatment with rilonacept reduced gout flares during urate-lowering therapy, according to a phase 3 study reported at the ACR meeting.
Ongoing treatment with rilonacept reduced gout flares during urate-lowering therapy, according to a phase 3 study reported at the ACR meeting.
Ongoing treatment with...
02/15/2011
First Report Managed Care
Feature
02/15/2011

Alice Goodman

Alice Goodman
As many as 20% of patients treated by PCPs for chronic lower back pain may actually have spondyloarthritis and should be referred to a rheumatologist for diagnosis and treatment, according to a study presented at the ACR meeting.
As many as 20% of patients treated by PCPs for chronic lower back pain may actually have spondyloarthritis and should be referred to a rheumatologist for diagnosis and treatment, according to a study presented at the ACR meeting.
As many as 20% of patients...
02/15/2011
First Report Managed Care
Feature
02/15/2011

Tim Casey

Tim Casey
Anaheim—Although there are a few targeted therapies available to treat patients with triple-negative breast cancer (TNBC), they are not effective. However, researchers are working on new therapies that can be used alone or in combination with...
Anaheim—Although there are a few targeted therapies available to treat patients with triple-negative breast cancer (TNBC), they are not effective. However, researchers are working on new therapies that can be used alone or in combination with...
Anaheim—Although there are a few...
02/15/2011
First Report Managed Care
Feature
02/15/2011

Tim Casey

Tim Casey
Anaheim—An analysis of 3-year patient drug costs for branded statin therapies found that patients taking atorvastatin were less costly for managed care health plans to cover than patients taking rosuvastatin or a combination of simvastatin...
Anaheim—An analysis of 3-year patient drug costs for branded statin therapies found that patients taking atorvastatin were less costly for managed care health plans to cover than patients taking rosuvastatin or a combination of simvastatin...
Anaheim—An analysis of 3-year...
02/15/2011
First Report Managed Care

Advertisement

Advertisement

Advertisement